<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="83955">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01872949</url>
  </required_header>
  <id_info>
    <org_study_id>PRO 04654 A</org_study_id>
    <nct_id>NCT01872949</nct_id>
  </id_info>
  <brief_title>C-Pulse® System European Multicenter Study</brief_title>
  <acronym>OPTIONS HF</acronym>
  <official_title>C-Pulse System eurOPean mulTicenter Study, Implantable cOuNterpulsation System in patIents With Moderate to Severe Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunshine Heart Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunshine Heart Inc.</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to observe the clinical outcomes of heart failure patients treated
      with C-Pulse® System in the usual manner and according to the approved indications and
      contraindications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the post-market clinical performance and safety of the C-Pulse® System for the
      treatment of Heart Failure in the population of patients who meet the approved clinical
      conditions provided in the indications and contraindications.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Freedom from worsening heart failure resulting in hospitalization, LVAD implantation, or death</measure>
    <time_frame>12 Months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>All Protocol Defined Adverse Events</measure>
    <time_frame>12 Months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in LVEF, QOL Scores and 6MHW</measure>
    <time_frame>6 and 12 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Moderate to Severe Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        A patient population of up to 50 patients with moderate to severe heart failure refractory
        to optimal medical therapy, who are implanted with the C-Pulse System as clinically
        appropriate, will be enrolled into the Study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is 18 years or older

          -  Patients with moderate to severe ambulatory heart failure [American College of
             Cardiology/American Heart Association (ACC/AHA) Stage C; NYHA Class III/IV
             ambulatory], who are refractory to optimal medical therapy

          -  Patients who are non-responders to CRT pacemaker therapy

          -  Patient has signed and dated the investigation informed consent form

        Exclusion Criteria:

          -  Evidence of significant ascending aortic calcification on postero-anterior chest
             X-ray or CT scan

          -  Moderate or severe atherosclerotic aortic disease

          -  Ascending aorto-coronary artery bypass grafts

          -  Any history of aortic dissection

          -  Connective tissue disorder such as Marfans disease

          -  Aorta not conforming to specified dimensional constraints

          -  Patient has severe mitral valve incompetence, grade 4+

          -  Patient has moderate to severe aortic valve incompetence, grade 2 - 4+

          -  Patient has systolic blood pressure less than 90 or greater than 140mmHg

          -  Presence of active systemic infection

          -  Presence of bleeding or coagulation disorder (relative)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Naomi Tatarek</last_name>
    <email>naomi.tatarek@sunshineheart.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Niederrhein</name>
      <address>
        <city>Duisburg</city>
        <state>Northrhine-Westfalia</state>
        <zip>47169</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gero Tenderich, MD</last_name>
      <phone>+49 203 5085401</phone>
    </contact>
    <investigator>
      <last_name>Gero Tenderich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Hetzer, MD</last_name>
      <phone>+49 30 45932000</phone>
    </contact>
    <investigator>
      <last_name>Roland Hetzer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardio-Centrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Hotz, MD</last_name>
      <phone>+ 49 30 206163636</phone>
    </contact>
    <investigator>
      <last_name>Holger Hotz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unfallkrankenhaus</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leo Bruch, MD</last_name>
      <phone>+49 305 681 3602</phone>
    </contact>
    <investigator>
      <last_name>Leo Bruch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Schmitto, MD</last_name>
      <email>schmitto.jan@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Jan Schmitto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 20, 2013</lastchanged_date>
  <firstreceived_date>June 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>NYHA Class III</keyword>
  <keyword>NYHA Class IV</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
